South Sudan remains resilient in fighting Covid-19

0 986

South Sudan has remained relentless in its efforts to contain further spread of the Covid-19 Two years after the first case was reported, followed by a record of 17,144 infections and 138 fatalities.

According to the World Health Organization (WHO), in the first six months of the pandemic, the youngest African nation had only one certified testing laboratory.

However, it currently has a reliable network of 32 GeneXpert machines repurposed to test Covid-19 and over 250 health facilities in remote settings that use antigen rapid diagnostic tests (Ag RDTs) to detect the presence of Covid-19.

The country has begun producing oxygen following the successful installation of its first oxygen plant at Juba Teaching Hospital.

In addition, the country upgraded its Public Health Emergency Operations Centre with an expansion of the facility.

The centre was also equipped with hardware and software to respond promptly and effectively to public health risks and emergencies of international concern.

These measures have been complemented by various government-imposed restrictions aimed at curbing the spread of Covid-19, as well as an ongoing mass vaccination drive that has so far seen more than 500,000 people fully vaccinated.

“South Sudan with support from partners since the start of the pandemic has been implementing necessary response measures including improving treatment testing, surveillance and vaccination. These measures have so far helped in slowing the transmission and save lives of many,” said Dr John Rumunu, the Director-General of Preventive Health Services, Ministry of Health.

Dr Rumunu noted that the pandemic had demonstrated the importance of preparedness to respond efficiently to health emergencies.

He acknowledged that the past two years have been challenging for the health sector, but that the country was emerging stronger and would be more resilient in the case of future emergencies.

CGTN/Olajumoke Adeleke

Leave A Reply

Your email address will not be published.